Accedi

Laura Heiser

Department of Biomedical Engineering,
Knight Cancer Institute,
Department of Biomedical Engineering, Knight Cancer Institute

Oregon Health and Science University

BIOGRAPHY

Laura Heiser has not added Biography.

If you are Laura Heiser and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer.

Molecular cancer therapeutics Dec, 2017 | Pubmed ID: 28958991

Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer.

Scientific reports Mar, 2019 | Pubmed ID: 30846826

BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer.

Oncogene Apr, 2019 | Pubmed ID: 30996246

INSTITUTIONS

Oregon Health and Science University

JOVE ARTICLES

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Rebecca Smith¹,

Kaylyn Devlin¹,

David Kilburn¹,

Sean Gross¹,

Damir Sudar²,

Elmar Bucher¹,

Michel Nederlof²,

Mark Dane¹,

Joe W. Gray¹,

Laura Heiser¹,

James E. Korkola¹

¹Department of Biomedical Engineering, Knight Cancer Institute, Oregon Health and Science University,

², Quantitative Imaging Systems LLC

Cancer Research

Riservatezza

Condizioni di utilizzo

Politiche

Contattaci

SUGGERISCI JOVE ALLA BIBLIOTECA

Newsletter di JoVE

Ricerca

JoVE Journal
Raccolta di metodi
JoVE Encyclopedia of Experiments
Archivio

Didattica

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Sportello unico per docenti
Faculty Site

Autori

Panoramica
Processo di pubblicazione
Comitato editoriale
Ambito e politiche
Revisione paritaria
Domande frequenti
Invia

Personale delle biblioteche

Panoramica
Testimonianze
Abbonamenti
Accesso
Risorse
Comitato consultivo della biblioteca
Domande frequenti

CHI SIAMO

Panoramica
Direzione
Blog
JoVE Help Center

Laura Heiser

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Biomedical Engineering,Knight Cancer Institute,Department of Biomedical Engineering, Knight Cancer Institute

Oregon Health and Science University

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Department of Biomedical Engineering,
Knight Cancer Institute,
Department of Biomedical Engineering, Knight Cancer Institute